ArticleSignal transduction and targeted therapy
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1.
Elizabeth A McNiel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
cites it